Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, human coagulation factor X (Coagadex®) cannot be endorsed for use within NHS Wales for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency. |
||
|
||
Medicine details |
||
| Medicine name | human coagulation factor X (Coagadex®) | |
| Formulation | 250 IU and 500 IU powder and solvent for solution for injection | |
| Reference number | 2910 | |
| Indication | Treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency |
|
| Company | Bio Products Laboratory Ltd | |
| BNF chapter | Nutrition & blood | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 26/07/2016 | |